Published in The BMJ · View the paper (DOI)
A study suggests that immunocompromised patients, particularly organ transplant recipients, require additional COVID-19 vaccine doses to boost antibody levels. The research found that seroconversion rates were significantly lower in these groups compared to healthy individuals, highlighting the need for targeted interventions.
Coverage from 2 institutions